Overcoming Barriers to Biosimilar Adoption: Commentary on "Cost to Medicare of Delayed Adalimumab Biosimilar Availability". Issue 1 (6th September 2021) - Arad, Nitzan; Kroetsch, Adam; McClellan, Mark